The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it. Moderna’s new option is a lower-dose version that is a step toward next-generation coronavirus vaccines. The company said in a statement Saturday that it expects to offer both the new vaccine and its existing COVID-19 shot this fall. The FDA approved the new vaccine for all adults 65 and older, and for people age 12 to 64 who are at higher risk from the coronavirus. That’s the same limit that the FDA set in licensing another vaccine option from Novavax.… Continue Reading